By disrupting receptor phosphorylation, CTCE‐9908 previously inhibited cellular responses associated with downstream signalling pathways of the CXCL12/CXCR4 axis and ultimately resulted in decreased levels of adhesion, proliferation and migration in several cancers.19 Here, CXCR4 is linked to cancer.